The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Function, structure and therapeutic potential of complement C5a receptors
Open accessAbstract
Complement fragment (C)5a is a 74 residue pro‐inflammatory polypeptide produced during activation of the complement cascade of serum proteins in response to foreign surfaces such as microorganisms and tissue damaged by physical or chemical injury. C5a binds to at least two seven‐transmembrane domain receptors, C5aR (C5R1, CD88) and C5L2 (gpr77), expressed ubiquitously on a wide variety of cells but particularly on the surface of immune cells like macrophages, neutrophils and T cells. C5aR is a classical G protein‐coupled receptor that signals through G α i and G α 16, whereas C5L2 does not appear to couple to G proteins and has no known signalling activity. Although C5a was first described as an anaphylatoxin and later as a leukocyte chemoattractant, the widespread expression of C5aR suggested more general functionality. Our understanding of the physiology of C5a has improved significantly in recent years through exploitation of receptor knockout and knockin mice, C5 and C5a antibodies, soluble recombinant C5a and C5a analogues and newly developed receptor antagonists. C5a is now also implicated in non‐immunological functions associated with developmental biology, CNS development and neurodegeneration, tissue regeneration, and haematopoiesis. Combined receptor mutagenesis, molecular modelling, structure‐activity relationship studies and species dependence for ligand potency on C5aR have been helpful for identifying ligand binding sites on the receptor and for defining mechanisms of receptor activation and inactivation. This review will highlight major developments in C5a receptor research that support C5aR as an important therapeutic target. The intriguing possibilities raised by the existence of a non‐signalling C5a receptor are also discussed. British Journal of Pharmacology (2007) 152, 429–448; doi:10.1038/sj.bjp.0707332; published online 2 July 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
G PROTEIN–COUPLED RECEPTOR KINASES
Pitcher, J. A., Freedman, N. J., & Lefkowitz, R. J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.653 · Cited by 1,361
Biology of the p21-Activated Kinases
Bokoch, G. M. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161742 · Cited by 1,089
Arthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693
The chemotactic receptor for human C5a anaphylatoxin
Gerard, N. P., & Gerard, C. (1991) · Nature · doi:10.1038/349614a0 · Cited by 655
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 594
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18817 · Cited by 575
Hammerschmidt, D., Hudson, L., Weaver, L. J., Craddock, P., & Jacob, H. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91403-8 · Cited by 556
Medical Treatment of Osteoarthritis
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91263-8 · Cited by 554
Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase
Bokisch, V. A., & Müller-Eberhard, H. J. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106462 · Cited by 517
Girardi, G., Yarilin, D., Thurman, J. M., Holers, V. M., & Salmon, J. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061022 · Cited by 508
The structural basis of arrestin-mediated regulation of G-protein-coupled receptors
Gurevich, V. V., & Gurevich, E. V. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.008 · Cited by 472
The proinflammatory mediators C3a and C5a are essential for liver regeneration
Strey, C. W., Markiewski, M., Mastellos, D., Tudoran, R., Spruce, L. A., Greenbaum, L. E., & Lambris, J. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030374 · Cited by 436
The Central Role of the Alternative Complement Pathway in Human Disease
Thurman, J. M., & Holers, V. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1305 · Cited by 432
Ribas, C., Penela, P., Murga, C., Salcedo, A., García-Hoz, C., Jurado-Pueyo, M., Aymerich, I., & Mayor, F. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.019 · Cited by 408
Directional Sensing Requires Gβγ-Mediated PAK1 and PIXα-Dependent Activation of Cdc42
Li, Z., Hannigan, M., Mo, Z., Liu, B., Lu, W., Wu, Y., Smrcka, A. V., Wu, G., Li, L., Liu, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00559-2 · Cited by 373
The Biology and Enzymology of Protein Tyrosine O-Sulfation
Moore, K. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300008200 · Cited by 360
The C5a chemoattractant receptor mediates mucosal defence to infection
Höpken, U. E., Lu, B., Gerard, N. P., & Gerard, C. (1996) · Nature · doi:10.1038/383086a0 · Cited by 344
Heteronuclear three-dimensional NMR spectroscopy of the inflammatory protein C5a
Zuiderweg, E. R. P., & Fesik, S. W. (1989) · Biochemistry · doi:10.1021/bi00432a008 · Cited by 329
THE ROLE OF THE COMPLEMENT SYSTEM IN ISCHEMIA-REPERFUSION INJURY
Arumugam, T. V., Shiels, I. A., Woodruff, T. M., Granger, D. N., & Taylor, S. M. (2004) · Shock · doi:10.1097/00024382-200405000-00002 · Cited by 327
Neurogenic Amplification of Immune Complex Inflammation
Bozic, C. R., Lu, B., Höpken, U. E., Gerard, C., & Gerard, N. P. (1996) · Science · doi:10.1126/science.273.5282.1722 · Cited by 325
Birney, E. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj133 · Cited by 310
Shushakova, N., Skokowa, J., Schulman, J., Baumann, U., Zwirner, J., Schmidt, R. E., & Gessner, J. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16577 · Cited by 284
Complement: a novel factor in basal and ischemia‐induced neurogenesis
Rahpeymai, Y., Hietala, M. A., Wilhelmsson, U., Fotheringham, A., Davies, I., Nilsson, A., Zwirner, J., Wetsel, R. A., Gerard, C., Pekny, M., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601004 · Cited by 279
C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses
Hawlisch, H., Belkaid, Y., Baelder, R., Hildeman, D., Gerard, C., & Köhl, J. (2005) · Immunity · doi:10.1016/j.immuni.2005.02.006 · Cited by 276
The ancient origin of the complement system
Zhu, Y., Thangamani, S., Ho, B., & Ding, J. L. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600533 · Cited by 262
C5L2, a Nonsignaling C5A Binding Protein
Okinaga, S., Slattery, D., Humbles, A., Zsengeller, Z., Morteau, O., Kinrade, M. B., Brodbeck, R. M., Krause, J. E., Choe, H.-R., Gerard, N. P., et al. (2003) · Biochemistry · doi:10.1021/bi034489v · Cited by 261
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans
Hillebrandt, S., Wasmuth, H. E., Weiskirchen, R., Hellerbrand, C., Keppeler, H., Werth, A., Schirin-Sokhan, R., Wilkens, G., Geier, A., Lorenzen, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1599 · Cited by 258
Mastellos, D., Papadimitriou, J. C., Franchini, S., Tsonis, P. A., & Lambris, J. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2479 · Cited by 255
Lawrence, I. D., Warner, J. A., Cohan, V. L., Hubbard, W. C., Kagey-Sobotka, A., & Lichtenstein, L. M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.3062 · Cited by 251
Haviland, D. L., McCoy, R. L., Whitehead, W. T., Akama, H., Molmenti, E. P., Brown, A., Haviland, J. C., Parks, W. C., Perlmutter, D. H., & Wetsel, R. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.4.1861 · Cited by 247
Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5a
Finch, A. M., Wong, A. K., Paczkowski, N. J., Wadi, S. K., Craik, D. J., Fairlie, D. P., & Taylor, S. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9806594 · Cited by 246
Self-citationCain, S. A., & Monk, P. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100714200 · Cited by 245
Self-citationC5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a
Chen, N.-J., Mirtsos, C., Suh, D., Lu, Y.-C., Lin, W.-J., McKerlie, C., Lee, T., Baribault, H., Tian, H., & Yeh, W.-C. (2007) · Nature · doi:10.1038/nature05559 · Cited by 243
Gasque, P., Singhrao, S. K., Neal, J. W., Götze, O., & Morgan, B. P. (1997) · Europe PMC (PubMed Central) · Cited by 234
Complement C3a and C5a Induce Different Signal Transduction Cascades in Endothelial Cells
Schraufstatter, I. U., Trieu, K., Sikora, L., Sriramarao, P., & DiScipio, R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2102 · Cited by 233
A chemogenomic analysis of the transmembrane binding cavity of human G‐protein‐coupled receptors
Surgand, J., Rodrigo, J., Kellenberger, E., & Rognan, D. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20768 · Cited by 220
Joost, P., & Methner, A. (2002) · Genome Biology · doi:10.1186/gb-2002-3-11-research0063 · Cited by 219
Van BEEK, J., ELWARD, K., & GASQUE, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03138.x · Cited by 218
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma
Kohl, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26582 · Cited by 217
Human T Cells Express the C5a Receptor and Are Chemoattracted to C5a
Nataf, S., Davoust, N., Ames, R. S., & Barnum, S. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4018 · Cited by 214
Chemotaxis by a CNS macrophage, the microglia
Yao, J., Harvath, L., Gilbert, D. L., & Colton, C. A. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270106 · Cited by 211
Drouin, S. M., Kildsgaard, J., Haviland, J., Zabner, J., Jia, H. P., McCray, P. B., Tack, B. F., & Wetsel, R. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.2025 · Cited by 208
Gasque, P., Singhrao, S. K., Neal, J. W., Wang, P., Sayah, S., Fontaine, M., & Morgan, B. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3543 · Cited by 207
A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats
Arumugam, T. V., Shiels, I. A., Strachan, A. J., Abbenante, G., Fairlie, D. P., & Taylor, S. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00737.x · Cited by 203
Self-citationAn Anti-inflammatory Function for the Complement Anaphylatoxin C5a-binding Protein, C5L2
Gerard, N. P., Lu, B., Liu, P., Craig, S., Fujiwara, Y., Okinaga, S., & Gerard, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500287200 · Cited by 201
Requirement and role of C5a in acute lung inflammatory injury in rats.
Mulligan, M. S., Schmid, E., Beck-Schimmer, B., Till, G. O., Friedl, H. P., Brauer, R. B., Hugli, T. E., Miyasaka, M., Warner, R. L., Johnson, K. J., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118818 · Cited by 200
Potential role of activated macrophages in acetaminophen hepatotoxicity
Laskin, D. L., & Pilaro, A. M. (1986) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(86)90051-7 · Cited by 194
Ohno, M., Hirata, T., Enomoto, M., Araki, T., Ishimaru, H., & Takahashi, T. A. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00067-5 · Cited by 194
Höpken, U. E., Lu, B., Gerard, N. P., & Gerard, C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.749 · Cited by 183
Expression and Function of C5a Receptor in Mouse Microvascular Endothelial Cells
Laudes, I. J., Chu, J. C., Huber-Lang, M., Guo, R.-F., Riedemann, N. C., Sarma, J. V., Mahdi, F., Murphy, H. S., Speyer, C., Lu, K. T., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5962 · Cited by 181
The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein
Kalant, D., Cain, S. A., Maslowska, M., Sniderman, A. D., Cianflone, K., & Monk, P. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206169200 · Cited by 175
Self-citationSnyderman, R., Phillips, J., & Mergenhagen, S. E. (1970) · Infection and Immunity · doi:10.1128/iai.1.6.521-525.1970 · Cited by 167
Protection of innate immunity by C5aR antagonist in septic mice
Huber‐Lang, M. S., Riedeman, N. C., Sarma, J. V., Younkin, E. M., McGuire, S. R., Laudes, I. J., Lu, K. T., Guo, R., Neff, T. A., Padgaonkar, V. A., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0209com · Cited by 161
Grant, E. P., Picarella, D., Burwell, T., Delaney, T., Croci, A., Avitahl, N., Humbles, A. A., Gutierrez-Ramos, J.-C., Briskin, M., Gerard, C., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020205 · Cited by 158
Essential role for the second extracellular loop in C5a receptor activation
Klco, J. M., Wiegand, C. B., Narzinski, K., & Baranski, T. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb913 · Cited by 158
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration
Woodruff, T. M., Crane, J. W., Proctor, L. M., Buller, K. M., Shek, A., Vos, K. J. D., Pollitt, S., Williams, H. M., Shiels, I. A., Monk, P. N., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5814com · Cited by 154
Self-citationAn essential role for complement C5a in the pathogenesis of septic cardiac dysfunction
Niederbichler, A. D., Hoesel, L. M., Westfall, M. V., Gao, H., Ipaktchi, K. R., Sun, L., Zetoune, F. S., Su, G. L., Arbabi, S., Sarma, J. V., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051207 · Cited by 153
Development of C5a receptor antagonists. Differential loss of functional responses.
Konteatis, Z. D., Siciliano, S. J., Riper, G. V., Molineaux, C. J., Pandya, S., Fischer, P. A., Rosen, H., Mumford, R. A., & Springer, M. S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.9.4200 · Cited by 151
Neuronal Expression of a Functional Receptor for the C5a Complement Activation Fragment
O’Barr, S. A., Caguioa, J., Gruol, D. L., Perkins, G. A., Ember, J. A., Hugli, T. E., & Cooper, N. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4154 · Cited by 149
Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell
Oskeritzian, C. A., Zhao, W. H., Min, H., Xia, H.-Z., Pozez, A. L., Kiev, J., & Schwartz, L. B. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.022 · Cited by 149
Bao, L., Osawe, I., Puri, T. S., Lambris, J. D., Haas, M., & Quigg, R. J. (2005) · European Journal of Immunology · doi:10.1002/eji.200526327 · Cited by 143
Sewell, D. L., Nacewicz, B. M., Liu, F., Macvilay, S., Erdei, A., Lambris, J. D., Sándor, M., & Fábry, Z. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.06.003 · Cited by 138
Pro-D-NMe-Amino Acid and D-Pro-NMe-Amino Acid: Simple, Efficient Reverse-Turn Constraints
Chalmers, D. K., & Marshall, G. R. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00127a004 · Cited by 137
Pertussis Toxin-sensitive Activation of Phospholipase C by the C5a and fMet-Leu-Phe Receptors
Jiang, H., Kuang, Y., Wu, Y., Smrcka, A. V., Simon, M. I., & Wu, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13430 · Cited by 137
Klco, J. M., Lassere, T. B., & Baranski, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305606200 · Cited by 133
Mapping of the C5a receptor signal transduction network in human neutrophils.
Buhl, A. M., Avdi, N. J., Worthen, G. S., & Johnson, G. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9190 · Cited by 132
Evidence for a functional role of the second C5a receptor C5L2
Gao, H., Neff, T. A., Guo, R., Speyer, C. L., Sarma, J. V., Tomlins, S. A., Man, Y., Riedemann, N. C., Hoesel, L. M., Younkin, E. M., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3424fje · Cited by 132
Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA‐salt hypertensive rats
Mirkovic, S., Seymour, A. L., Fenning, A. S., Strachan, A. J., Margolin, S. B., Taylor, S. M., & Brown, L. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704539 · Cited by 129
Novel Therapeutic Targets for Acute Pancreatitis and Associated Multiple Organ Dysfunction Syndrome
Bhatia, M. (2002) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010023344517 · Cited by 128
Baranski, T., Herzmark, P., Lichtarge, O., Gerber, B. O., Trueheart, J., Meng, E. C., Iiri, T., Sheikh, S. P., & Bourne, H. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15757 · Cited by 126
CXCL12 and C5a trigger cell migration via a PAK1/2-p38α MAPK-MAPKAP-K2-HSP27 pathway
Rousseau, S., Dolado, I., Beardmore, V. A., Shpiro, N., Márquez, R., Nebreda, Á. R., Arthur, J. S. C., Case, L. C., Tessier‐Lavigne, M., Gaestel, M., et al. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.02.006 · Cited by 124
la Sala, A., Gadina, M., & Kelsall, B. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2994 · Cited by 123
C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway
Perianayagam, M. C., Balakrishnan, V. S., King, A. J., Pereira, B. J. G., & Jaber, B. L. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00139.x · Cited by 123
G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin.
Ballesteros, J., & Palczewski, K. (2001) · PubMed · Cited by 122
Regulation by C5a of Neutrophil Activation during Sepsis
Riedemann, N. C., Guo, R., Bernacki, K. D., Reuben, J. S., Laudes, I. J., Neff, T. A., Gao, H., Speyer, C. L., Sarma, V. J., Zetoune, F. S., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00206-1 · Cited by 121
C5a Initiates the Inflammatory Cascade in Immune Complex Peritonitis
Godau, J., Heller, T., Hawlisch, H., Trappe, M., Howells, E., Best, J. L., Zwirner, J., Verbeek, J. S., Hogarth, P. M., Gerard, C. J., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3437 · Cited by 121
Tsuji, R. F., Kawiková, I., Ramabhadran, R., Akahira-Azuma, M., Taub, D. D., Hugli, T. E., Gerard, C. J., & Askenase, P. W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1588 · Cited by 120
Skokowa, J., Ali, S. R., Felda, O., Kumar, V. V., Konrad, S., Shushakova, N., Schmidt, R. E., Piekorz, R. P., Nürnberg, B., Spicher, K., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3041 · Cited by 119
Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation
Hammerschmidt, D. E., Bowers, T. K., Lammi-Keefe, C. J., Jacob, H., & Craddock, P. R. (1980) · Blood · doi:10.1182/blood.v55.6.898.898 · Cited by 117
DeMartino, J. A., Riper, G. V., Siciliano, S. J., Molineaux, C. J., Konteatis, Z. D., Rosen, H., & Springer, M. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36643-7 · Cited by 114
Complement Factors C3a, C4a, and C5a in Chronic Obstructive Pulmonary Disease and Asthma
Marc, M. M., Korošec, P., Košnik, M., Kern, I., Fležar, M., Šuškovič, S., & Šorli, J. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0394oc · Cited by 114
Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).
Huey, R., & Hugli, T. E. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.3.2063 · Cited by 109
Kijlstra, A., Heij, E. C. L., & Hendrikse, F. (2005) · Ocular Immunology and Inflammation · doi:10.1080/09273940590909185 · Cited by 108
Albizu, L., Balestre, M., Breton, C., Pin, J., Manning, M., Mouillac, B., Barberis, C., & Durroux, T. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025684 · Cited by 108
Pulmonary Fibrosis Correlates with Duration of Tissue Neutrophil Activation
Jones, H. A., Schofield, J. B., Krausz, T. N., Boobis, A. R., & Haslett, C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.2.9711075 · Cited by 107
Bälder, R., Fuchs, B., Bautsch, W., Zwirner, J., Köhl, J., Hoymann, H.-G., Glaab, T., Erpenbeck, V. J., Krug, N., & Braun, A. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.783 · Cited by 106
Complement C5a Receptor Is Essential for the Optimal Generation of Antiviral CD8+ T Cell Responses
Kim, A. H. J., Dimitriou, I. D., Holland, M. C., Mastellos, D. C., Mueller, Y. M., Altman, J. D., Lambris, J. D., & Katsikis, P. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2524 · Cited by 106
Expression and Function of the C5a Receptor in Rat Alveolar Epithelial Cells
Riedemann, N. C., Guo, R., Sarma, V. J., Laudes, I. J., Huber-Lang, M. S., Warner, R. L., Albrecht, E. A., Speyer, C. L., & Ward, P. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1919 · Cited by 104
Becker, E. L. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.135.2.376 · Cited by 104
Ottonello, L. C., Corcione, A., Tortolina, G., Airoldi, I., Albesiano, E., Favre, A., D’Agostino, R., Malavasi, F., Pistoia, V., & Dallegri, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6510 · Cited by 103
Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis
Kiener, H. P., Baghestanian, M., Dominkus, M., Walchshofer, S., Ghannadan, M., Willheim, M., Sillaber, C., Graninger, W. B., Smolen, J. S., & Valent, P. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199802)41:2<233::aid-art7>3.0.co;2-v · Cited by 103
Strachan, A. J., Woodruff, T. M., Haaima, G., Fairlie, D. P., & Taylor, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6560 · Cited by 102
Self-citationIdentification of four novel human G protein-coupled receptors expressed in the brain
Lee, D.-K., George, S. R., Cheng, R., Nguyen, T., Liu, Y., Brown, M., Lynch, K. R., & O’Dowd, B. F. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00242-4 · Cited by 101
Zuiderweg, E. R. P., Nettesheim, D. G., Mollison, K. W., & Carter, G. W. (1989) · Biochemistry · doi:10.1021/bi00427a025 · Cited by 100
Identification of a Potent and Orally Active Non-peptide C5a Receptor Antagonist
Sumichika, H., Sakata, K., Sato, N., Takeshita, S., Ishibuchi, S., Nakamura, M., Kamahori, T., Ehara, S., Itoh, K., Ohtsuka, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209672200 · Cited by 99
Morgan, E. L., Ember, J. A., Sanderson, S. D., Scholz, W. W., Buchner, R., Ye, R. D., & Hugli, T. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.1.377 · Cited by 98
Fayyazi, A., Scheel, O., Werfel, T., Schweyer, S., Oppermann, M., Götze, O., Radzun, H., & Zwirner, J. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00911.x · Cited by 98
Arumugam, T. V., Shiels, I. A., Woodruff, T. M., Reid, R. C., Fairlie, D. P., & Taylor, S. M. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2002.6369 · Cited by 96
Self-citationExpression of the anaphylatoxin C5a receptor in non-myeloid cells
Zwirner, J., Fayyazi, A., & Götze, O. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00109-1 · Cited by 95
Constitutively Active Gα16 Stimulates STAT3 via a c-Src/JAK- and ERK-dependent Mechanism
Lo, R. K. H., Cheung, H. O.-L., & Wong, Y. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307299200 · Cited by 93
McCarthy, K. A., & Henson, P. M. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.6.2511 · Cited by 92
Complement in allergy and asthma
Gerard, N. P., & Gerard, C. J. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00410-7 · Cited by 89
Kuroki, M., & O’Flaherty, J. T. (1999) · Biochemical Journal · doi:10.1042/bj3410691 · Cited by 89
Milligan, G., Ramsay, D., Pascal, G., & Carrillo, J. J. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.005 · Cited by 89
C5a receptor and thymocyte apoptosis in sepsis
Riedemann, N. C., Guo, R., Laudes, I. J., Keller, K. A., Sarma, V. J., Padgaonkar, V. A., Zetoune, F. S., & Ward, P. A. (2002) · The FASEB Journal · doi:10.1096/fj.02-0033fje · Cited by 86
Complement-induced histamine release from human basophils. I. Generation of activity in human serum.
Hook, W. A., Siraganian, R. P., & Wahl, S. M. (1975) · PubMed · Cited by 85
Farzan, M., Schnitzler, C. E., Vasilieva, N. Y., Leung, D. G., Kuhn, J. H., Gerard, C. J., Gerard, N. P., & Choe, H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1059 · Cited by 85
Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann, M., & Götze, O. (1994) · PubMed · Cited by 83
Ali, H., Fisher, I. B., Haribabu, B., Richardson, R. M., & D, R. S. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.11706 · Cited by 82
Wong, A. K., Finch, A. M., Pierens, G. K., Craik, D. J., Taylor, S. M., & Fairlie, D. P. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9800651 · Cited by 82
Self-citationHammerschmidt, D. E., Greenberg, C. S., Yamada, O., Craddock, P. R., & Jacob, H. S. (1981) · PubMed · Cited by 82
Gerard, N. P., Lu, B., He, X. P., Eddy, R. L., Shows, T. B., & Gerard, C. J. (1993) · Biochemistry · doi:10.1021/bi00056a007 · Cited by 81
Drug evaluation: the C5a receptor antagonist PMX-53.
Köhl, J. (2006) · PubMed · Cited by 80
Changes in the Novel Orphan, C5a Receptor (C5L2), during Experimental Sepsis and Sepsis in Humans
Huber-Lang, M. S., Sarma, J. V., Rittirsch, D., Schreiber, H. A., Weiss, M., Flierl, M. A., Younkin, E. M., Schneider, M., Suger-Wiedeck, H., Gebhard, F. T., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1104 · Cited by 80
Self-citationBuck, E. A., & Wells, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500016102 · Cited by 80
Zhang, X., Boyar, W. C., Toth, M. J., Wennogle, L. P., & Gonnella, N. C. (1997) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(199706)28:2<261::aid-prot13>3.0.co;2-g · Cited by 79
Natural IgM antibodies: The orphaned molecules in immune surveillance
Vollmers, H. P., & Brändlein, S. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.08.007 · Cited by 79
Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
Epps, D. E. V., & Chenoweth, D. E. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.6.2862 · Cited by 78
Perianayagam, M. C., Balakrishnan, V. S., Pereira, B. J. G., & Jaber, B. L. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01273.x · Cited by 78
An Activation Switch in the Ligand Binding Pocket of the C5a Receptor
Gerber, B. O., Meng, E. C., Dötsch, V., Baranski, T., & Bourne, H. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007748200 · Cited by 78
Proctor, L. M., Arumugam, T. V., Shiels, I. A., Reid, R. C., Fairlie, D. P., & Taylor, S. M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705819 · Cited by 76
Self-citationNeutrophil direction sensing and superoxide production linked by the GTPase-activating protein GIT2
Mazaki, Y., Hashimoto, S., Tsujimura, T., Morishige, M., Hashimoto, A., Aritake, K., Yamada, A., Nam, J., Kiyonari, H., Nakao, K., et al. (2006) · Nature Immunology · doi:10.1038/ni1349 · Cited by 76
Mery, L., & Boulay, F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41884-9 · Cited by 75
Denecke, B., Meyerdierks, A., & Böttger, E. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.26860 · Cited by 75
Braun, L., Christophe, T., & Boulay, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210120200 · Cited by 74
Soruri, A., Kim, S., Kiafard, Z., & Zwirner, J. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00052-x · Cited by 73
C5a Mutants Are Potent Antagonists of the C5a Receptor (CD88) and of C5L2
Otto, M., Hawlisch, H., Monk, P. N., Müller, M., Klos, A., Karp, C. L., & Köhl, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310078200 · Cited by 72
Self-citationNaik, N. R., Giannini, E., Brouchon, L., & Boulay, F. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.19.2381 · Cited by 72
Complement-Induced Histamine Release from Human Basophils
Hook, W. A., Siraganian, R. P., & Wahl, S. M. (1975) · The Journal of Immunology · doi:10.4049/jimmunol.114.4.1185 · Cited by 72
Gavrilyuk, V., Kalinin, S., Hilbush, B. S., Middlecamp, A., McGuire, S. O., Pelligrino, D. A., Weinberg, G. L., & Feinstein, D. L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02942.x · Cited by 69
Morgan, E. L., Thoman, M. L., Weigle, W. O., & Hugli, T. E. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.3.1257 · Cited by 69
Effects of a new C5a receptor antagonist on C5a‐ and endotoxin‐ induced neutropenia in the rat
Short, A. J., Wong, A. K., Finch, A. M., Haaima, G., Shiels, I. A., Fairlie, D. P., & Taylor, S. M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702338 · Cited by 69
Self-citationGutzmer, R., Köther, B., Zwirner, J., Dijkstra, D., Purwar, R., Wittmann, M., & Werfel, T. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700416 · Cited by 69
Floyd, D. H., Geva, A., Bruinsma, S. P., Overton, M. C., Blumer, K., & Baranski, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305607200 · Cited by 69
Weisman, H. F., Bartow, T. A., Leppo, M. K., Boyle, M., Marsh, H. C., Carson, G. R., Roux, K., Weisfeldt, M. L., & Fearon, D. T. (1990) · PubMed · Cited by 67
Johswich, K. O., Martin, M., Thalmann, J., Rheinheimer, C., Monk, P. N., & Klos, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609734200 · Cited by 67
Self-citationLee, H., Zahra, D., Vogelzang, A., Newton, R. A., Thatcher, J., Quan, A., So, T., Zwirner, J., Köentgen, F., Padkjær, S. B., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1248 · Cited by 66
Soruri, A., Kiafard, Z., Dettmer, C., Riggert, J., Köhl, J., & Zwirner, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3306 · Cited by 65
Stahel, P. F., Kariya, K., Shohami, E., Barnum, S. R., Eugster, H., Trentz, O., Kossmann, T., & Morganti-Kossmann, M. C. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00304-0 · Cited by 65
Abe, M., Shibata, K., Akatsu, H., Shimizu, N., Sakata, N., Katsuragi, T., & Okada, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4651 · Cited by 64
Haynes, D. R., Harkin, D. G., Bignold, L. P., Hutchens, M. J., Taylor, S. M., & Fairlie, D. P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00361-0 · Cited by 63
Self-citationThe Role of the N-terminal Domain of the Complement Fragment Receptor C5L2 in Ligand Binding
Scola, A.-M., Higginbottom, A., Partridge, L. J., Reid, R. C., Woodruff, T. M., Taylor, S. M., Fairlie, D. P., & Monk, P. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609178200 · Cited by 62
Self-citationDaveau, M., Bénard, M., Scotté, M., Schouft, M., Hiron, M., François, A., Salier, J., & Fontaine, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3418 · Cited by 60
Klco, J. M., Nikiforovich, G. V., & Baranski, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600548200 · Cited by 59
Identification and synthesis of a receptor binding site of human anaphylatoxin C5a
Kawai, M., Quincy, D. A., Lane, B. C., Mollison, K. W., Luly, J. R., & Carter, G. W. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00111a022 · Cited by 59
Langkabel, P., Zwirner, J., & Oppermann, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199909)29:09<3035::aid-immu3035>3.0.co;2-z · Cited by 58
Martin, S. E., Chenoweth, D. E., Engler, R. L., Roth, D. M., & Longhurst, J. C. (1988) · Circulation Research · doi:10.1161/01.res.63.2.483 · Cited by 58
Fleming, S. D., Mastellos, D. C., Karpel‐Massler, G., Shea‐Donohue, T., Lambris, J. D., & Tsokos, G. C. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00160-8 · Cited by 58
Finch, A. M., Vogen, S. M., Sherman, S., Kirnarsky, L., Taylor, S. M., & Sanderson, S. D. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960727r · Cited by 57
Strachan, A. J., Shiels, I. A., Reid, R. C., Fairlie, D. P., & Taylor, S. M. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704417 · Cited by 56
Self-citationGenetic Mapping of the Human C5a Receptor
Geva, A., Lassere, T. B., Lichtarge, O., Pollitt, S. K., & Baranski, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005602200 · Cited by 56
Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis
Reiman, R. M., Gerard, C. J., Campbell, I. L., & Barnum, S. R. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200204)32:4<1157::aid-immu1157>3.0.co;2-m · Cited by 54
Higginbottom, A., Cain, S. A., Woodruff, T. M., Proctor, L. M., Madala, P. K., Tyndall, J. D. A., Taylor, S. M., Fairlie, D. P., & Monk, P. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410797200 · Cited by 54
Self-citationRhoG Regulates the Neutrophil NADPH Oxidase
Condliffe, A. M., Webb, L. M. C., Ferguson, G., Davidson, K., Turner, M., Vigorito, E., Manifava, M., Chilvers, E. R., Stephens, L., & Hawkins, P. T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5314 · Cited by 53
Autoimmunity and tyrosine sulfation
Hsu, W., Rosenquist, G. L., Ansari, A. A., et al. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.03.004 · Cited by 52
Probing the “Message:Address” Sites for Chemoattractant Binding to the C5a Receptor
Kolakowski, L. F., Lu, B., Gerard, C. J., & Gerard, N. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.18077 · Cited by 51
Woodruff, T. M., Strachan, A. J., Sanderson, S. D., Monk, P. N., Wong, A. K., Fairlie, D. P., & Taylor, S. M. (2001) · Inflammation · doi:10.1023/a:1011036414353 · Cited by 49
Self-citationFayyazi, A., Sandau, R., Duong, L. Q., Götze, O., Radzun, H., Schweyer, S., Soruri, A., & Zwirner, J. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65295-9 · Cited by 49
Analysis of C5a-mediated chemotaxis by lentiviral delivery of small interfering RNA
Hwang, J., Fraser, I. D. C., Choi, S., Qin, F. X.-F., & Simon, M. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307549100 · Cited by 49
Expression of the anaphylatoxin C5a receptor in the oligodendrocyte lineage
Nataf, S., Levison, S. W., & Barnum, S. R. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02003-0 · Cited by 46
Complement regulates inhalation tolerance at the dendritic cell/T cell interface
Köhl, J., & Wills-Karp, M. A. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.06.016 · Cited by 46
Human- B and T-lymphocyte locomotion in response to casein, C5a, and f-Met-Leu-Phe
El‐Naggar, A. K., Epps, D. E. V., & Williams, R. C. (1980) · Cellular Immunology · doi:10.1016/0008-8749(80)90112-4 · Cited by 45
Schnatbaum, K., Locardi, E., Scharn, D., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.07.036 · Cited by 45
Structure and function of the Wiskott-Aldrich syndrome protein
Ochs, H. D., & Notarangelo, L. D. (2005) · Current Opinion in Hematology · doi:10.1097/01.moh.0000168520.98990.19 · Cited by 45
Hwang, J., Choi, S., Fraser, I. D. C., Chang, M. S., & Simon, M. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503503102 · Cited by 44
Schieferdecker, H. L., Schlaf, G., Koleva, M., Götze, O., & Jungermann, K. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5453 · Cited by 43
Yamamoto, T. (2006) · Pathology International · doi:10.1111/j.1440-1827.2007.02049.x · Cited by 42
Chemotaxis of germinal centers B cells in response to C5a
Kupp, L. I., Kosco, M. H., Schenkein, H. A., & Tew, J. G. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211108 · Cited by 42
Koleva, M., Schlaf, G., Landmann, R. M., Götze, O., Jungermann, K. A., & Schieferdecker, H. L. (2002) · Gastroenterology · doi:10.1053/gast.2002.31883 · Cited by 40
Site-specific Disulfide Capture of Agonist and Antagonist Peptides on the C5a Receptor
Buck, E. A., Bourne, H. R., & Wells, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400500200 · Cited by 40
Mast cell‐expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis
Mullaly, S. C., & Kubes, P. (2006) · European Journal of Immunology · doi:10.1002/eji.200636405 · Cited by 40
Development of C5a receptor antagonists.
Wong, A. K., Taylor, S. M., & Fairlie, D. P. (1999) · PubMed · Cited by 39
Self-citationChimeric Receptors of the Human C3a Receptor and C5a Receptor (CD88)
Crass, T., Ames, R. S., Sarau, H. M., Tornetta, M. A., Foley, J. J., Köhl, J., Klos, A., & Bautsch, W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8367 · Cited by 39
Monk, P. N., & Partridge, L. J. (1993) · Biochemical Journal · doi:10.1042/bj2950679 · Cited by 39
Self-citationEffects of anti‐C5a monoclonal antibodies on oxygen use in a porcine model of severe sgifis
Möhr, Höpken, Oppermann, Mathes, Goldmann, Siever, Götze, & Burchardi (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00260.x · Cited by 37
Bock, D., Martin, U., Gärtner, S., Rheinheimer, C., Raffetseder, U., Arseniev, L., Barker, M. D., Monk, P. N., Bautsch, W., Köhl, J., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270631 · Cited by 33
Self-citationC5a receptor-mediated production of IL-8 by the human retinal pigment epithelial cell line, ARPE-19
Fukuoka, Y., & Medof, M. E. (2001) · Current Eye Research · doi:10.1076/ceyr.23.5.320.5437 · Cited by 33
Méry, L., & Boulay, F. (1993) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1993.tb01609.x · Cited by 31
Perianayagam, M. C., Madias, N. E., Pereira, B. J. G., & Jaber, B. L. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01637.x · Cited by 31
Borders, C. W., Courtney, A. N., Ronen, K., Laborde‐Lahoz, M. P., Guidry, T., Hwang, S., Olsen, M. R., Hunter, R. L., Hollmann, T. J., Wetsel, R. A., et al. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2005.01643.x · Cited by 30
Expression and induction of anaphylatoxin C5a receptors in the rat liver.
Schlaf, G., Schmitz, M., Rothermel, E., Jungermann, K. A., Schieferdecker, H. L., & Götze, O. (2003) · PubMed · doi:10.14670/hh-18.299 · Cited by 28
An unexpected role for the anaphylatoxin C5a receptor in allergic sensitization
Lambrecht, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27876 · Cited by 27
Sun, J., Ember, J. A., Chao, T., Hugli, T. E., Fukuoka, Y., & Ye, R. D. (1999) · Protein Science · doi:10.1110/ps.8.11.2304 · Cited by 26
Zahn, S., Zwirner, J., Spengler, H., & Götze, O. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270420 · Cited by 26
Blockade of p38 map kinase inhibits complement-induced acute lung injury in a murine model
Nash, S. P., & Heuertz, R. M. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.06.005 · Cited by 25
Hunt, J. R., Martin, C. B., & Martin, B. K. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.01.002 · Cited by 23
Tardif, M., Brouchon, L., Rabiet, M., & Boulay, F. (2003) · Biochemical Journal · doi:10.1042/bj20021803 · Cited by 21
Connelly, M. A., Moulton, R. A., Smith, A. K., Lindsey, D. R., Sinha, M., Wetsel, R. A., & Jagannath, C. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005582 · Cited by 21
Weinmann, O., Gutzmer, R., Zwirner, J., Wittmann, M., Langer, K., Lisewski, M., Mommert, S., Kapp, A., & Werfel, T. (2003) · Immunology · doi:10.1111/j.1365-2567.2003.01764.x · Cited by 20
A Comprehensive Structure-Function Map of the Intracellular Surface of the Human C5a Receptor
Matsumoto, M. L., Narzinski, K., Kiser, P. D., Nikiforovich, G. V., & Baranski, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607679200 · Cited by 20
Hagemann, I. S., Narzinski, K., Floyd, D. H., & Baranski, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607686200 · Cited by 20
Barnes, K. C., Caraballo, L. R., Muñoz, M., Zambelli-Weiner, A., Ehrlich, E., Burki, M., Jiménez, S., Mathias, R. A., Stockton, M. L., Deindl, P., et al. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.1942.x · Cited by 19
Mario Governa, M. A. (2000) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/009841000156664 · Cited by 18
Schlaf, G., Schmitz, M., Heine, I., Demberg, T., Schieferdecker, H. L., & Götze, O. (2004) · PubMed · doi:10.14670/hh-19.1165 · Cited by 18
Governa, M., Amati, M., Fenoglio, I., Valentino, M., Coloccini, S., Bolognini, L., Carlo Botta, G., Emanuelli, M., Pierella, F., Volpe, A. R., et al. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.019 · Cited by 16
Regulation of Complement 5a Receptor Expression in U937 Cells by Phorbol Ester
Rubin, J. E., Titus, L., & Nanes, M. S. (1991) · Journal of Leukocyte Biology · doi:10.1002/jlb.50.5.502 · Cited by 15
Chemotactic activity in periodontal disease: I. The role of complement in monocyte chemotaxis
Okada, H., & Silverman, M. S. (1979) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1979.tb00214.x · Cited by 14
Biostability and blood-contacting properties of sulfonate grafted polyurethane and Biomer
Wabers, H. D., McCoy, T. J., Okkema, A. Z., Hergenrother, R. W., Wolf, M. F., & Cooper, S. L. (1993) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856292x00349 · Cited by 12
Bordenave, G. (1995) · Bulletin de l Institut Pasteur · doi:10.1016/0020-2452(96)81487-4 · Cited by 12
Cited by
Complement and its role in innate and adaptive immune responses
Dunkelberger, J. R., & Song, W.-C. (2010) · Cell Research · doi:10.1038/cr.2009.139 · Cited by 1,932
Modulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 778
The role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Complement-targeted therapeutics
Ricklin, D., & Lambris, J. D. (2007) · Nature Biotechnology · doi:10.1038/nbt1342 · Cited by 481
Metadata
- Authors
- Monk, P. N., Scola, A., Madala, P., & Fairlie, D. P.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-10
- Volume
- 152
- Issue
- 4
- Pages
- 429-448
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2053443014
- Cited by
- 404
- References
- 199
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.